ENGN FY 2024 Earnings — enGene Holdings Inc. Revenue & Financial Results | Market Cap Arena

ENGNenGene Holdings Inc.

$359M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$323,000

Operating Income

$62M

Net Income

-$55M

EPS (Diluted)

$-1.46

Cash Flow

Operating Cash Flow

-$48M

Free Cash Flow

-$49M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$311M

Total Liabilities

$39M

Stockholders' Equity

$273M

Cash & Equivalents

$173M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$323,000	-$175,000	-84.6%
Operating Income	$62M	-$26M	+339.1%
Net Income	-$55M	-$100M	+44.8%